11:21 Debate: Brentuximab vedotin as upfront therapy for advanced Hodgkin lymphoma? - Yes HMP Education
16:47 Debate: Will CAR-T cell therapies have a major impact in recurrent DLBCL over the next 3 years - No HMP Education
23:21 Who should receive treatment with something beyond R-CHOP for aggressive lymphoma? HMP Education
15:25 Debate: Young patient with recurrent follicular lymphoma and short remission? - Transplant therapies HMP Education
15:02 Debate: Will novel-agent based combination therapy become standard of care for CLL? - No HMP Education
14:18 Debate: Young patient with recurrent follicular lymphoma and short remission? - Novel agents/chemo HMP Education
12:46 Debate: How should IPSS-R intermediate risk MDS be approached? - As higher risk disease HMP Education
20:53 Novel small molecules in multiple myeloma: Update on key results from emerging clinical studies HMP Education
